AAAAAA
Results:
1-25
|
Results: 25
Authors:
Glaser, V
Fossel, MB
Citation: V. Glaser et Mb. Fossel, Aging research institute, J ANTI-AG M, 4(3), 2001, pp. 187-192
Authors:
Glaser, V
Rose, MR
Citation: V. Glaser et Mr. Rose, An interview with Michael R. Rose, Ph.D., J ANTI-AG M, 4(3), 2001, pp. 193-196
Authors:
Glaser, V
Brummel-Smith, K
Citation: V. Glaser et K. Brummel-smith, American Geriatric Society, J ANTI-AG M, 4(2), 2001, pp. 105-109
Authors:
Glaser, V
Melov, S
Citation: V. Glaser et S. Melov, An interview with Simon Melov, Ph.D., J ANTI-AG M, 4(2), 2001, pp. 111-114
Authors:
Glaser, V
Cohen, H
George, L
Schutz, C
Citation: V. Glaser et al., Organizational profile - Gerontological Society of America, J ANTI-AG M, 4(1), 2001, pp. 3-7
Authors:
Glaser, V
Guarente, L
Citation: V. Glaser et L. Guarente, Pieces of the puzzle - An interview with Leonard Guarente, Ph.D., J ANTI-AG M, 4(1), 2001, pp. 9-12
Authors:
Glaser, V
Schauer, PR
Citation: V. Glaser et Pr. Schauer, Interview with the expert: Philip R. Schauer, MD, J LAP ADV A, 11(5), 2001, pp. 315-318
Authors:
Beykirch, H
Glaser, V
Citation: H. Beykirch et V. Glaser, Rate of recirculation and efficiency of LDL apheresis in unilateral and bilateral venous access?, NIEREN HOCH, 30(1), 2001, pp. 7-10
Authors:
Richter, V
Rassoul, F
Reuter, W
Purcz, T
Julius, U
Glaser, V
Hentschel, B
Wagner, O
Citation: V. Richter et al., Effect of extracorporeal low-density lipoprotein elimination on circulating cell adhesion molecules in patients with hypercholesterolemia, AM J CARD, 87(9), 2001, pp. 1111-1113
Authors:
Glaser, V
Harman, D
Lane, MA
Citation: V. Glaser et al., Organizational profile - American Aging Association, J ANTI-AG M, 3(4), 2000, pp. 419-423
Authors:
Weindruch, R
Glaser, V
Citation: R. Weindruch et V. Glaser, Pieces of the puzzle - An interview with Richard Weindruch, Ph.D., J ANTI-AG M, 3(4), 2000, pp. 425-429
Authors:
Glaser, V
Temple, R
Citation: V. Glaser et R. Temple, The Food and Drug Administration, J ANTI-AG M, 3(3), 2000, pp. 229-234
Authors:
Glaser, V
Campisi, J
Citation: V. Glaser et J. Campisi, An interview with Judith Campisi, Ph.D., J ANTI-AG M, 3(3), 2000, pp. 235-239
Authors:
Glaser, V
Citation: V. Glaser, Roslin Institute, J ANTI-AG M, 3(2), 2000, pp. 137-141
Authors:
Glaser, V
Jazwinski, SM
Citation: V. Glaser et Sm. Jazwinski, An interview with S. Michal Jazwinski, Ph.D., J ANTI-AG M, 3(2), 2000, pp. 143-147
Authors:
Glaser, V
Citation: V. Glaser, The Kronos Group, J ANTI-AG M, 3(1), 2000, pp. 3-7
Authors:
Glaser, V
Citation: V. Glaser, An interview with Robert Arking, Ph.D., J ANTI-AG M, 3(1), 2000, pp. 9-13
Authors:
Glaser, V
Citation: V. Glaser, Cloned cows turn back the cellular clock, NAT BIOTECH, 18(6), 2000, pp. 594-594
Authors:
Glaser, V
Citation: V. Glaser, Geron issued UK Dolly patents, NAT BIOTECH, 18(3), 2000, pp. 256-257
Authors:
Glaser, V
Kemp, JP
Citation: V. Glaser et Jp. Kemp, In my opinion - Interview with the expert, PED ASTHMA, 14(2), 2000, pp. 145-148
Authors:
Glaser, V
Bartelmez, S
Citation: V. Glaser et S. Bartelmez, Investigator profile, J HEMATH ST, 8(5), 1999, pp. 459-464
Authors:
Glaser, V
Citation: V. Glaser, Sugen's strategy: a signal for P&U purchase, NAT BIOTECH, 17(8), 1999, pp. 745-746
Authors:
Glaser, V
Citation: V. Glaser, Genentech relaunched with independence intact, NAT BIOTECH, 17(7), 1999, pp. 634-634
Authors:
Glaser, V
Citation: V. Glaser, Competition between flu drugs feverishly anticipated, NAT BIOTECH, 17(11), 1999, pp. 1059-1059
Authors:
Glaser, V
Citation: V. Glaser, Billion-dollar market blossoms as botanicals take root, NAT BIOTECH, 17(1), 1999, pp. 17-18
Risultati:
1-25
|